Publication Cover
Redox Report
Communications in Free Radical Research
Volume 22, 2017 - Issue 6
1,389
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Assessment of serum thiol/disulfide homeostasis in multiple myeloma patients by a new method

, , , , , , , & show all

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2015;65:5–29. doi: 10.3322/caac.21254
  • Bergsagel PL. Epidemiology, etiology, and molecular pathogenesis. In: Richardson PG, Anderson KC, (eds.) Multiple Miyeloma. London & Chicago: Remedica Publishing; 2004. p. 1–24.
  • Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1–40. doi: 10.1016/j.cbi.2005.12.009
  • Gupte A, Rusell JM. Elevated copper and oxidative stres in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009;35:32–46. doi: 10.1016/j.ctrv.2008.07.004
  • Sharma A, Tripathi M, Satyam A, Kumar L. Study of antioxidant levels in patients with multiple myeloma. Leukemia Lymphoma 2009;50:809–15. doi: 10.1080/10428190902802323
  • Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 2000;72 (2 Suppl): 653S–69S.
  • Turell L, Radi R, Alvarez B. The thiol pool in plasma: the central contribution of albümin to redox processes. Free Radic Biol Med 2013;65:244–53. doi: 10.1016/j.freeradbiomed.2013.05.050
  • Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. J Biol Chem 2013;288:26489–96. doi: 10.1074/jbc.R113.462929
  • Jones DP, Liang Y. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 2009;47:1329–38. doi: 10.1016/j.freeradbiomed.2009.08.021
  • Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 2006;28:551–64. doi: 10.1016/j.bcp.2005.10.044
  • Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010;48:749–62. doi: 10.1016/j.freeradbiomed.2009.12.022
  • Prabhu A, Sarcar B, Kahali S, Yuan Z, Johnson JJ, Adam KP et al. Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. Cancer Res 2014;74:787–96. doi: 10.1158/0008-5472.CAN-13-1423
  • Ergin M, Cendek BD, Neselioglu S, Avsar AF, Erel O. Dynamic thiol-disulfide homeostasis in hyperemesis gravidarum. J Perinatol 2015;35:788–92. doi: 10.1038/jp.2015.81
  • Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H, Neselioglu S, et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulfide homeostasis. Am J Emerg Med 2015;33:1567–71. doi: 10.1016/j.ajem.2015.06.016
  • Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel O, et al. Determination of thiol/disulfide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016;51(1):47–51. doi: 10.1007/s12020-015-0784-6
  • Erel O, Neselioglu S. A novel and automated assay for thiol/disulfide homeostasis. Clin Biochem 2014;47:326–32. doi: 10.1016/j.clinbiochem.2014.09.026
  • Popa-Wagner A, Mitran S, Sivanesan S, Chang E, Buga AM. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev 2013;2013:963520. doi: 10.1155/2013/963520
  • Zima T, Štipek S, Crkovská J, Plátenik J, Merta M, Tesaŕ V. Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma. Neoplasma 1996;43:69–73.
  • Gangemi S, Allegra A, Alonci A, Cristani M, Russo S, Speciale A, et al. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflamm. Res 2012;61:1063–7. doi: 10.1007/s00011-012-0498-7
  • Kuku I, Aydogdu I, Bayraktar N, Kaya E, Akyok O, Erkurt MA. Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma. Cell Biochem Funct 2005;23:47–50. doi: 10.1002/cbf.1127
  • Mehdi WA, Zainulabdeen JA, Mehde AA. Investigation of the antioxidant status in multiple myeloma patients: effects of therapy. Asian Pac J Cancer Prev 2013;14:3663–7. doi: 10.7314/APJCP.2013.14.6.3663
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–11. doi: 10.1016/j.clinbiochem.2005.08.008
  • Ellidag HY, Aydin O, Eren E, Yilmaz N, Ergin M. Decreased hdl-dependent paraoxonase and arylesterase enzyme activity may indicate a worse prognosis in multiple myeloma. Asian Pac J Cancer Prev 2014;15:9847–51. doi: 10.7314/APJCP.2014.15.22.9847
  • Faridvant Y, Oskuyi AE, Khadem-Ansari MH. Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma. Redox Rep 2016;26:1–5.
  • Imbesi S, Musolino C, Allegra A, Saija A, Morabito F, Calapai G, et al. Oxidative stress in oncohematologic diseases: an update. Expert Rev Hematol 2013;6:317–25. doi: 10.1586/ehm.13.21
  • Ellidah HY, Eren E, Aydin O, Yildirim M, Sezer C, Yilmaz N. Multiple myeloma: relationship to antioxidant esterases. Med Princ Prac 2014;23:18–23. doi: 10.1159/000355826

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.